West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
354.07
+5.47 (1.57%)
Aug 7, 2026, 4:00 PM EDT - Market closed

WST Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, WST stock has a consensus rating of "Strong Buy" and an average price target of $404.73. The average 1-year stock price forecast is 14.31% higher than the current stock price, while the lowest is $340 (-3.97%) and the highest is $459 (+29.64%).

Price Target: $404.73 (+14.31%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$340$404.73$410$459
Change-3.97%+14.31%+15.80%+29.64%

Analyst Ratings

The average analyst rating for WST stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy111010101111
Buy222223
Hold333312
Sell000010
Strong Sell000000
Total161515151516

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Citi
Citi
Buy
Maintains
$400$412
BuyMaintains$400$412+16.36%Aug 3, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
$410$425
BuyMaintains$410$425+20.03%Jul 27, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$410
BuyReiterates$410+15.80%Jul 24, 2026
Barclays
Barclays
Buy
Maintains
$400
BuyMaintains$400+12.97%Jul 24, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$365$410
BuyReiterates$365$410+15.80%Jul 23, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.37B
from 3.07B
Increased by 9.77%
Revenue Next Year
3.59B
from 3.37B
Increased by 6.30%
EPS This Year
8.96
from 7.29
Increased by 22.89%
EPS Next Year
9.96
from 8.96
Increased by 11.23%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.83B2.89B2.95B2.89B3.07B3.37B
Revenue Growth
31.89%1.95%2.18%-1.92%6.25%9.77%
Gross Profit
1.18B1.14B1.13B998.50M1.10B1.27B
Gross Margin
41.59%39.36%38.31%34.51%35.91%37.55%
Operating Income
768.60M763.80M706.20M593.60M638.70M757.53M
Net Income
661.80M585.90M593.40M492.70M493.70M614.55M
EPS
----7.298.96
EPS Growth
----8.00%22.89%
Forward PE
53.5534.8442.2345.9036.6939.52
Dividend / Share
0.690.730.770.810.850.90
Dividend Growth
-5.80%5.48%5.19%4.94%6.18%
Free Cash Flow
210.05M246.54M196.35M206.73M273.88M454.73M
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High3.4B
Avg3.4B
Low3.4B

Revenue Growth

Revenue Growth202620272028
High
10.7%
Avg
9.8%
Low
9.3%

EPS Forecast

EPS202620272028
High9.05
Avg8.96
Low8.83

EPS Growth

EPS Growth202620272028
High
24.1%
Avg
22.9%
Low
21.1%